Acquired Anti-factor VII (Proconvertin) Inhibitor: Hemorrhage and Thrombosis

• References

• 1 Campbell E, Sanal S, Mattson J, Walker L, Estry S, Mueller L, Schwarz M, Hampton S. Factor VII inhibitor. Am J Med 1980; 68: 962-4.
• 2 Delmer A, Horellou MH, Andreu G, Lecompte T, Rossi F, Kazatchkine MD, Samama M, Zittoun R. Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody. Blood 1989; 74: 229-32.
• 3 De Raucourt E, Dumont MD, Tourani JM, Hubsch JP, Riquet M, Fischer AM. Acquired factor VII deficiency associated with pleural liposarcoma. Blood Coag and Fibrinol 1994; 5: 833-6.
• 4 Godal HC, Madsen K, Nissen-Meyer R. Thrombo-embolism in patients with total proconvertin (factor VII) deficiency. Acta Med Scand 1962; 171: 325-7.
• 5 Hall CA, Rapaport SI, Ames SB, De Groot JA, Allen ES, Ralston MA. A clinical and family study of hereditary proconvertin (factor VII) deficiency. Am J Med 1964; 37: 172-81.
• 6 Schulman S, Johnsson H, Lindmarker P. Thrombotic complications after substitution with a FVII concentrate. Thromb Haemost 1991; 66: 619.
• 7 Escoffre M, Zini JM, Schliamser L, Mazoyer E, Soria C, Tobelem G, Dupuy E. Severe arterial thrombosis in a congenitally factor VII deficient patient. Br J Haematol 1995; 91: 739-41.
• 8 Cohen AJ, Kessler CM. Acquired inhibitors. Baillieres Clin Haematol 1996; 9: 331-54.